Skip to content
★ Sign in to follow
JG
Total declarations
46
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (21 ops.)
€966k

Latest filing published 07 Apr 2009 for Veradigm Inc., €43k.

Insider track record

Disclosed buys
0
Disclosed sells
21
Signal history

No signal scores available.

John G. Cull: trading record in brief

John G. Cull appears in our data through filings on Veradigm Inc. shares, published by SEC (Form 4). Over a trading history stretching from 23 February 2005 to 16 March 2009, the count stands at 46 filings.

No open-market purchase appears, only 21 sales worth €966k. Other entries cover 11 share grants and 14 option exercises. In 2009 alone, the filings show no purchases and 1 sale.

The record was last updated on 7 April 2009 with a share grant (€43k) in Veradigm Inc. The median gap between a trade and its publication by SEC (Form 4) is 26 days. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to John G. Cull

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations46 total
  • ◆
    President, Medication ServicesExecutivesVeradigm Inc.
    55,689 USD0SEC
    6,438 shares@ US$8.65Common StockSEC:0001181431-09-019344:0
  • ◇
    President, Medication ServicesExecutivesVeradigm Inc.
    7,542 USD0SEC
    7,856 shares@ US$0.96Common StockSEC:0001181431-09-003170:0
  • ▼
    President, Medication ServicesExecutivesVeradigm Inc.
    103,309 USD0SEC
    12,154 shares@ US$8.50Common StockSEC:0001181431-09-003170:1
  • ◆
    President, Medication ServicesExecutivesVeradigm Inc.
    0SEC
    21,854 shares0Common StockSEC:0001181431-09-001857:0
  • ◆
    President, Medication ServicesExecutivesVeradigm Inc.
    9,616 USD0SEC
    954 shares@ US$10.08Common StockSEC:0001181431-08-057206:0
  • ◆
    President, Medication ServicesExecutivesVeradigm Inc.
    9,094 USD0SEC
    1,037 shares@ US$8.77Common StockSEC:0001181431-08-057206:1
  • ◆
    President, Medication ServicesExecutivesVeradigm Inc.
    4,974 USD0SEC
    380 shares@ US$13.09Common StockSEC:0001181431-08-052461:0
  • ▼
    President, Medication ServicesExecutivesVeradigm Inc.
    2,831 USD0SEC
    195 shares@ US$14.52Common StockSEC:0001181431-08-050701:0
  • ◇
    President, Medication ServicesExecutivesVeradigm Inc.
    6,000 USD0SEC
    3,000 shares@ US$2.00Common StockSEC:0001181431-08-037151:0
  • ▼
    President, Medication ServicesExecutivesVeradigm Inc.
    37,500 USD0SEC
    3,000 shares@ US$12.50Common StockSEC:0001181431-08-037151:1
  • ▼
    President, Medication ServicesExecutivesVeradigm Inc.
    4,369 USD0SEC
    194 shares@ US$22.52Common StockSEC:0001181431-08-023686:0
  • ◇
    President, Medication ServicesExecutivesVeradigm Inc.
    8,000 USD0SEC
    4,000 shares@ US$2.00Common StockSEC:0001181431-08-014120:0
  • ▼
    President, Medication ServicesExecutivesVeradigm Inc.
    61,956 USD0SEC
    5,163 shares@ US$12.00Common StockSEC:0001181431-08-014120:1
  • ◆
    President, Medication ServicesExecutivesVeradigm Inc.
    6,319 USD0SEC
    404 shares@ US$15.64Common StockSEC:0001181431-08-004578:0
  • ◆
    President, Medication ServicesExecutivesVeradigm Inc.
    0SEC
    4,320 shares0Common StockSEC:0001181431-07-057401:0
  • ◆
    President, Medication ServicesExecutivesVeradigm Inc.
    4,331 USD0SEC
    185 shares@ US$23.41Common StockSEC:0001181431-07-054664:0
  • ◇
    President, Medication ServicesExecutivesVeradigm Inc.
    67,500 USD0SEC
    10,000 shares@ US$6.75Common StockSEC:0001181431-07-017312:0
  • ▼
    President, Medication ServicesExecutivesVeradigm Inc.
    255,400 USD0SEC
    10,000 shares@ US$25.54Common StockSEC:0001181431-07-017312:1
  • ◆
    President, Medication ServicesExecutivesVeradigm Inc.
    11,563 USD0SEC
    405 shares@ US$28.55Common StockSEC:0001181431-07-004971:0
  • ◇
    President, Medication ServicesExecutivesVeradigm Inc.
    300 USD0SEC
    5,000 shares@ US$0.06Common StockSEC:0001181431-06-051668:0
  • ▼
    President, Medication ServicesExecutivesVeradigm Inc.
    105,000 USD0SEC
    5,000 shares@ US$21.00Common StockSEC:0001181431-06-051668:1
  • ◇
    President, Medication ServicesExecutivesVeradigm Inc.
    12,498 USD0SEC
    4,166 shares@ US$3.00Common StockSEC:0001181431-06-051668:2
  • ▼
    President, Medication ServicesExecutivesVeradigm Inc.
    87,486 USD0SEC
    4,166 shares@ US$21.00Common StockSEC:0001181431-06-051668:3
  • ◆
    President, Medication ServicesExecutivesVeradigm Inc.
    0SEC
    2,500 shares0Common StockSEC:0001181431-06-051661:0
  • ◇
    President, Medication ServicesExecutivesVeradigm Inc.
    11,700 USD0SEC
    5,000 shares@ US$2.34Common StockSEC:0001181431-06-025559:0

25 of 46 declarations